OTC and Hyperammonemia: For example, Yang et al. [118] succeeded in rescuing lethal hyperammonemia from a chow diet after neonatal i.v. injection of rAAVs carrying CRISPR components, whereas gene correction through tail vein injection in adult OTC-deficient mice failed to rescue lethal hyperammonemia from a chow diet.